Editor`s Picks

November has been the best month of the year for U.S. stocks counting since 1950 AII investor sentiment has improved—although it remains below the historical average However, 2022 keeps adding...

Pfizer (NYSE:PFE) faces a $16 to $18 billion loss in revenue from 2025 through 2030 as it loses essential patents on five drugs.The drugs account for 40% of the company's Q3 revenue when its COVID...

Share repurchases might be on increase as firms pivot from a new tax in 2023 Management teams appear to be accelerating stock buybacks PKW ETF offers exposure to value and cyclical stocks while...

CPI reading due in China on Tuesday, in the US on Thursday China reiterates commitment to COVID-zero approach US CPI could give timeline on Fed rate pivot Weak number could signal recession From the...

It is a big week, with the CPI report on Thursday and a bunch of government bond auctions later this week. That means rates will be on the move, and word that the China zero covid policy will remain...

A low CPI will lower outlook for rate hikes Polls have Republicans in lead; Democratic surprise win will raise fears of more spending Last week, yield curve inverted the most in 40 years Two...

Peloton is down 73.9% year-to-date and 94.5% from its January 2021 record high Expect more pain ahead for the embattled company. "The ship is turning," Peloton (NASDAQ:PTON) CEO Barry McCarthy...

The Fed told markets what they didn't want to hear. Rates would need to be higher than previously thought, and with that, rates across the curve and the dollar are moving higher. Both rates and the...